Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Japan Tobacco ( (JP:2914) ) has shared an announcement.
Japan Tobacco’s Canadian subsidiary, JTI-Macdonald Corp., along with its co-defendants, is working towards settling all pending tobacco-related claims in Canada, with a proposed settlement plan involving a payment of 32.5 billion Canadian dollars. The settlement, which is still subject to court approval, will result in JT recording a provision for litigation losses in fiscal year 2024, but it will not affect the planned dividend per share.
More about Japan Tobacco
Japan Tobacco Inc. (JT) is a global company based in Tokyo, Japan, and is publicly traded on the Tokyo Stock Exchange. The company operates in three segments: tobacco, pharmaceutical, and processed food. Its tobacco products, including brands like Winston, Camel, MEVIUS, and LD, are sold in over 130 markets. JT is also investing in Reduced-Risk Products, such as its Ploom heated tobacco line, and is committed to sustainable contributions to its stakeholders.
YTD Price Performance: -4.85%
Average Trading Volume: 548
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $44.19B
For a thorough assessment of 2914 stock, go to TipRanks’ Stock Analysis page.